MMI Raises $125M To Scale Robotic Microsurgery
MMI raised $125 million in Series D funding led by BioStar Capital to expand access to its Symani robotic microsurgery system and fund a clinical trial exploring whether it can help clear neurotoxins linked to Alzheimer's progression.